Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Mexiletine for treatment of myotonia: a trial triumph for rare disease networks.

Hoffman EP, Kaminski HJ.

JAMA. 2012 Oct 3;308(13):1377-8. doi: 10.1001/jama.2012.12906. No abstract available.

2.

[Ion-channel related muscular diseases].

Fontaine B.

Rev Med Interne. 1999 Sep;20(9):774-80. Review. French.

PMID:
10522299
3.

Tocainide and mexiletine. Orally effective lidocaine analogues.

Roden DM.

Arch Intern Med. 1985 Mar;145(3):417-8. Review. No abstract available.

PMID:
3919665
4.
5.

Mexiletine: pharmacology and therapeutic use.

Manolis AS, Deering TF, Cameron J, Estes NA 3rd.

Clin Cardiol. 1990 May;13(5):349-59. Review.

6.

Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.

Snyder DW.

J La State Med Soc. 1989 May;141(5):21-5. Review.

PMID:
2499645
7.

Ventricular arrhythmias. An assessment of newer therapeutic agents.

Skluth H, Grauer K, Gums J.

Postgrad Med. 1989 May 1;85(6):137-8, 141-8, 153. Review. No abstract available.

PMID:
2496401
8.

Class 1B agents lidocaine, mexiletine, tocainide, phenytoin.

Rizzon P, Di Biase M, Favale S, Visani L.

Eur Heart J. 1987 Mar;8 Suppl A:21-5. Review. No abstract available.

PMID:
3107988
9.

Recurrent ventricular tachycardia in a patient with continuous flow left ventricle assist device: Successful management with radiofrequency ablation and medical treatment.

Romano G, Raffa GM, Ruggieri A, Sgarito G, Falletta C, Sciacca S, Pilato M, Clemenza F.

Int J Cardiol. 2015;190:198-200. doi: 10.1016/j.ijcard.2015.04.141. Review. No abstract available.

PMID:
25920023
10.

Mexiletine: a new type I antiarrhythmic agent.

Schrader BJ, Bauman JL.

Drug Intell Clin Pharm. 1986 Apr;20(4):255-60. Review.

PMID:
2421992
Items per page

Supplemental Content

Support Center